Medline (Nasdaq:MDLN) posted fourth-quarter results that topped sales expectations but fell short of earnings forecasts.

Delivered strong full year 2025 results Completed Initial Public Offering Introduced full year 2026 guidance Fourth quarter net sales of $7.8 ...

Medline reported lower fourth-quarter profit, dragged down partially by tariffs, in its first earnings release since its initial public offering in December. The medical and surgical products company ...

Medline boost syringe stock with BD to maintain 45-day inventory, improving supply chain resilience amid FDA import restrictions on China-made syringes.

Medline delivered strong sales despite net income decreases in the fourth quarter and 2025 in its first quarterly filing since becoming a publicly traded company last year.

Medline (NASDAQ:MDLN) outlined strong top-line growth in 2025 and issued 2026 guidance that reflects continued momentum from new customer wins alongside ongoing tariff pressure, during the company’s f ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Medline recalls 4,300 blood culture kits due to packaging defects that could cause sterility issues with BD ChloraPrep components.

Medline Inc. MDLN has identified electrical safety risks with its Medline Basic Homecare Beds that may lead to fire.

Medline's founding family (from left to right): Jim Abrams, Charlie Mills and Andy Mills. Five members of the Illinois-based Mills family joined the three-comma club on Wednesday, as the nearly ...

A Relative Strength Rating upgrade for Medline shows improving technical performance.

The FDA said hand pendants and cords may overheat, causing the devices to spark, burn, melt, smoke and catch fire.